Filing Details
- Accession Number:
- 0001493152-20-023851
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2020-12-17 17:02:50
- Reporting Period:
- 2019-09-12
- Accepted Time:
- 2020-12-17 17:02:50
- Original Submission Date:
- 2019-09-12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1642380 | Oncocyte Corp | OCX | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1383492 | S Mitchell Levine | C/O Oncocyte Corporation 15 Cushing Irvine CA 92618 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-09-12 | 10,000 | $2.01 | 13,495 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price of $2.006 per share represents a weighted average of prices ranging from $2.003 to $2.006 per share. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Person on September 12, 2019, which erroneously did not combine the shares of common stock acquired by the Reporting Person on September 12, 2019 with the Reporting Person's common stock reported on his Form 4 on July 31, 2018.
Billionaire Hedge Funds
